On June 22, 2021, Shenzhen Salubris Pharmaceuticals Co., Ltd. (SZSE:002294) closed the transaction. The company has issued 68,800,535 shares at a price of CNY 28.37 per share for the gross proceeds of CNY 1,951,871,177.95. The transaction included participation from China Southern Fund Management Co., Ltd. for 8,988,365 shares for the gross proceeds of CNY 254,999,915.05, Jinan Jiangshan Investment Partnership (Limited Partnership) for 7,049,700 shares for the gross proceeds of CNY 199,999,989, Caitong Fund Management Co., Ltd. for 5,837,142 shares for the gross proceeds of CNY 165,599,718.54, Li Jianfeng for 4,582,305 shares for the gross proceeds of CNY 129,999,992.85, Ruiyuan Fund Management Co., Ltd. for 4,582,305 shares for the gross proceeds of CNY 129,999,992.85, China Merchants Securities Co., Ltd. for 4,582,305 shares for the gross proceeds of CNY 129,999,992.85, Luo Huanxiao for 4,229,820 shares for the gross proceeds of CNY 119,999,993.4, Wang Guohua for 4229820 shares for the gross proceeds of CNY 119,999,993.4, Guotai Junan Securities Co., Ltd. for 4,088,826 shares for the gross proceeds of CNY 115,999,993.62, Shanghai SITICO Assets Management Co., Ltd. for 3,524,850 shares for the gross proceeds of CNY 9,999,9994.5, Beijing Times Fuxing Investment Management Co., Ltd.-Times Fuxing Panshi No.

6 Private Equity Securities Investment Fund for 3,172,365 shares for the gross proceeds of CNY 89,999,995.05, Du Qunfei for 2,467,395 shares for the gross proceeds of CNY 69,999,996.15, China Securities Co., Ltd. for 2,185,407 shares for the gross proceeds of CNY 61,999,996.59, Shenzhen Tairun Haiji Asset Management Co., Ltd.-Tairun Yuxin Venture Capital No. 6 Private Equity Securities Investment Fund for 2150158 shares for the gross proceeds of CNY 60999982.46, Nordisk Fund Management Co., Ltd. for 2114907 shares for the gross proceeds of CNY 59999911.59, E Fund Management Co., Ltd. for 2114910 shares for the gross proceeds of CNY 59999996.7, Zheng Lei for 2114910 shares for the gross proceeds of CNY 59999996.7, UBS AG for 785045 shares for the gross proceeds of CNY 22271726.65,